Fluticasone Propionate/Formoterol Fumarate Hydrate

丙酸氟替卡松/富马酸福莫特罗

Report date: 2025/11/14 13:58:52

Base Information

Drug NameFluticasone Propionate/Formoterol Fumarate Hydrate
Drug Alias NameFluticasone Propionate/Formoterol Fumarate富马酸福莫特罗/丙酸氟替卡松Fluticasone Propionate and Formoterol Fumarate HydrateFluticasone propionate - formoterol fumarate hydrateFormoterol fumarate/fluticasone propionate +[12] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionBeta-2 adrenergic receptor agonistsGlucocorticoid receptor agonistsCytosolic phospholipase A2 agonists
TargetsBeta-2 adrenergic receptorGlucocorticoid receptorCytosolic phospholipase A2
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsAsthma
Approved Indications in ChinaAsthma
Original Approved Country/TerritoryIndia
Original Approved Date2006/05/10
Country/TerritoryCzechiaBulgariaUnited States +[29] 
CombinationsYes Formoterol FumarateFluticasone Propionate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesRanbaxy IncKyorin Holdings Inc
China Registration ClassN/A

Develop Information

Active CompaniesKyorin Holdings IncNapp Pharmaceutical Holdings Ltd
Inactive CompaniesMundipharma Research LtdNapp Pharmaceuticals LtdSkyepharma Ag +[7] 
Active IndicationsAsthma
Inactive IndicationsPulmonary Disease, Chronic Obstructive

Other Information

ATC CodeR03AK11
Related LinksKEGG